KIF23 and colorectal carcinoma: To exclude the possibility that NAT10 might mediate the stability of KIF23 protein, we treated CRC cells with the protein translation inhibitor cycloheximide (CHX) (100 μg/mL) and observed a mild effect on KIF23 protein stability (Fig. 5N and Fig. S5O).